Science Corp Secures $230M Funding for Brain-Computer Interface Development Science Corp has successfully raised $230 million in venture capital to accelerate the development of brain-computer interface technology. This significant funding round represents a major investment in neurotechnology innovation and positions the company as a key player in the emerging BCI market. The capital will support research, development, and commercialization efforts aimed at creating advanced neural interfaces with potential medical and consumer applications. Brain-computer interfaces represent a rapidly growing sector attracting substantial investor interest due to their therapeutic potential in treating neurological conditions and enhancing human capability. The funding demonstrates strong confidence from venture investors in the company's technical roadmap and market opportunity.